Elisa G.

Experience

• 

  PPD

  Jan 2005 - Jan 2008

  Feasibility Coordinator

  •Feasibility coordinator for all therapeutic areas in Mexico and Central America; preparation and customization of Confidential and Non-Disclosure Agreements, feasibility questionnaires, feasibility weekly progress reports, interviews with key opinion leaders, preparation of site profile forms.•Key point of contact for Principal Investigators, Strategic Site Collaborations, Client local operating company, and Institutional Review Boards.

• 

  Covance

  Jan 2008 - Jan 2013

  Regional Manager- Feasibility & Investigator Relations

  •Development of the 360° Methodology for Site Selection used to assess the site’s potential for all Feasibility Networks by Indication, Feasibilities, Study Start Up and Rescue Programs in Canada, US and Latin America. •Regional coordination of local teams for feasibilities including site identification, investigator outreach, top level feasibility with blinded materials, full feasibility with execution of non-disclosure agreements, or scientific interviews with the Key Opinion Leaders in all therapeutic areas. Show less

• 

  PPD

  Jan 2014 - Jan 2015

  Sr. Manager, Strategic Feasibility

  •Head of the Site Prioritization Team in charge of the deployment of the site list to be used for feasibility for all Global phase I to IV studies based on data mining of internal and external site metrics for performance, start up, and previous experience in similar studies. •Close collaboration with site Start-Up teams, Feasibility Strategists, Project Management and the sponsor to accelerate the site selection process and reduce time from award to pre-study visit (PSV).

• 

  PRA Health Sciences

  Aug 2015 - now

  Sr. Startup Lead Early Phase Oncology

  Head and primary point of escalation for project startup activities. Assess and communicates impact of project scope on timelines changes and local resource requirements. Responsible for system compliance and management of startup team.

• 

  Parexel

  Oct 2018 - now

  Early Phase Development in Oncology, Rare Disease, and CNS. Provides guidance on study strategy, considering a project’s complexities and challenges to determine the most appropriate operational and resourcing strategy for successful operational delivery

  • Integrated Solutions Consultant

    Jun 2021 - now

  • Strategic Feasibility (Early Phase)

    Oct 2018 - now